Akari Therapeutics Balance Sheet Health
Financial Health criteria checks 2/6
Akari Therapeutics has a total shareholder equity of $-6.7M and total debt of $1,000.0K, which brings its debt-to-equity ratio to -14.9%. Its total assets and total liabilities are $2.7M and $9.4M respectively.
Key information
-14.9%
Debt to equity ratio
US$1.00m
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.25m |
| Equity | -US$6.69m |
| Total liabilities | US$9.43m |
| Total assets | US$2.73m |
Recent financial health updates
Recent updates
Akari Therapeutics GAAP EPS of $0.00
Sep 27Will Akari Therapeutics (NASDAQ:AKTX) Spend Its Cash Wisely?
Sep 20
Akari Therapeutics announces positive results from pre-clinical studies of eye disease treatment
Jul 28Akari Therapeutics GAAP EPS of $0.00
Jul 20Patient completes course with Akari's stem cell transplant related complication treatment
Jul 07We're Keeping An Eye On Akari Therapeutics' (NASDAQ:AKTX) Cash Burn Rate
Dec 31Akari shares rise after FDA 'fast track' status for skin disease treatment nomacopan
Apr 28Akari Therapeutics reports FY results
Apr 21We Think Akari Therapeutics (NASDAQ:AKTX) Needs To Drive Business Growth Carefully
Mar 15Do Institutions Own Akari Therapeutics, Plc (NASDAQ:AKTX) Shares?
Jan 21Read This Before Selling Akari Therapeutics, Plc (NASDAQ:AKTX) Shares
Dec 17Akari Therapeutics updates trial progress; returns to profitability
Dec 11Akari Therapeutics' lead candidate shows encouraging preclinical action against inflammatory eye disease
Dec 03Financial Position Analysis
Short Term Liabilities: AKTX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: AKTX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: AKTX has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: AKTX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AKTX has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: AKTX is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.